Literature DB >> 19133256

MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells.

Antonio Strillacci1, Cristiana Griffoni, Pasquale Sansone, Paola Paterini, Giulia Piazzi, Giorgia Lazzarini, Enzo Spisni, Maria Abbondanza Pantaleo, Guido Biasco, Vittorio Tomasi.   

Abstract

Overexpressed cyclooxygenase-2 (COX-2) strongly contributes to the growth and invasiveness of tumoral cells in patients affected by colorectal cancer (CRC). It has been demonstrated that COX-2 overexpression depends on different cellular pathways involving both transcriptional and post-transcriptional regulations. We assumed that COX-2 expression could be regulated also by microRNAs (miRNAs) since these short RNA molecules participate to the fine regulation of several genes implicated in cell growth and differentiation. In this paper, we report the inverse correlation between COX-2 and miR-101 expression in colon cancer cell lines and we demonstrated in vitro the direct inhibition of COX-2 mRNA translation mediated by miR-101. Moreover, this correlation was supported by data collected ex vivo, in which colon cancer tissues and liver metastases derived from CRC patients were analyzed. These findings provide a novel molecular insight in the modulation of COX-2 at post-transcriptional level by miR-101 and strengthen the observation that miRNAs are highly implicated in the control of gene expression. An impairment of miR-101 levels could represent one of the leading causes of COX-2 overexpression in colon cancer cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19133256     DOI: 10.1016/j.yexcr.2008.12.010

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  112 in total

1.  MicroRNA-101 downregulates Alzheimer's amyloid-β precursor protein levels in human cell cultures and is differentially expressed.

Authors:  Justin M Long; Debomoy K Lahiri
Journal:  Biochem Biophys Res Commun       Date:  2010-12-21       Impact factor: 3.575

Review 2.  The role of microRNAs in colorectal cancer.

Authors:  Aaron J Schetter; Hirokazu Okayama; Curtis C Harris
Journal:  Cancer J       Date:  2012 May-Jun       Impact factor: 3.360

Review 3.  MicroRNA and AU-rich element regulation of prostaglandin synthesis.

Authors:  Ashleigh E Moore; Lisa E Young; Dan A Dixon
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

4.  MicroRNA-101 inhibits angiogenesis via COX-2 in endometrial carcinoma.

Authors:  Ying Liu; Haiyan Li; Congying Zhao; Hanbing Jia
Journal:  Mol Cell Biochem       Date:  2018-02-05       Impact factor: 3.396

5.  MicroRNA-101 inhibits growth of epithelial ovarian cancer by relieving chromatin-mediated transcriptional repression of p21(waf¹/cip¹).

Authors:  Assaad Semaan; Aamer M Qazi; Shelly Seward; Sreedhar Chamala; Christopher S Bryant; Sanjeev Kumar; Robert Morris; Christopher P Steffes; David L Bouwman; Adnan R Munkarah; Donald W Weaver; Scott A Gruber; Ramesh B Batchu
Journal:  Pharm Res       Date:  2011-08-05       Impact factor: 4.200

Review 6.  Noncoding RNA and colorectal cancer: its epigenetic role.

Authors:  Yoshiaki Kita; Keiichi Yonemori; Yusaku Osako; Kenji Baba; Shinichiro Mori; Kosei Maemura; Shoji Natsugoe
Journal:  J Hum Genet       Date:  2016-06-09       Impact factor: 3.172

7.  Role of microRNAs in resveratrol-mediated mitigation of colitis-associated tumorigenesis in Apc(Min/+) mice.

Authors:  Ibrahim Altamemi; E Angela Murphy; James F Catroppo; Elizabeth E Zumbrun; Jiajia Zhang; Jamie L McClellan; Udai P Singh; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Pharmacol Exp Ther       Date:  2014-05-09       Impact factor: 4.030

Review 8.  How microRNAs influence both hereditary and inflammatory-mediated colon cancers.

Authors:  Jennifer Hutchison; Zoe Cohen; Benjamin C Onyeagucha; Janet Funk; Mark A Nelson
Journal:  Cancer Genet       Date:  2013-09-14

Review 9.  Cancer prevention by aspirin in children with Constitutional Mismatch Repair Deficiency (CMMRD).

Authors:  Erika K S M Leenders; Harm Westdorp; Roger J Brüggemann; Jan Loeffen; Christian Kratz; John Burn; Nicoline Hoogerbrugge; Marjolijn C J Jongmans
Journal:  Eur J Hum Genet       Date:  2018-06-14       Impact factor: 4.246

Review 10.  MicroRNAs in colorectal cancer: translation of molecular biology into clinical application.

Authors:  Ondrej Slaby; Marek Svoboda; Jaroslav Michalek; Rostislav Vyzula
Journal:  Mol Cancer       Date:  2009-11-14       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.